Iwata City Hospital
Iwata, Shizuoka, 438-8550, Japan
NCT Number: NCT00307996
The purpose of this study is to examine whether CoQ10 administration is effective as an antioxidant in hemodialysis patients.
Looking for future studies?
Notify Me0 year–85 year
All sexes
Interventional
Phase 4
Iwata, Shizuoka, 438-8550, Japan
Oxidative stress has been recognized as a potential risk factor for such complications as atherosclerosis in hemodialysis patients. This study investigates whether CoQ10 administration is effective for protecting oxidative stress in hemodialysis patients. The subjects were recruited from day-time hemodialysis patients in Iwata City Hospital. 100 mg CoQ10 was administered every HD for 6 months. Several oxidative and antioxidative markers were measured in plasma at pre, 1, 3, 6 months and after washout.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
University of Shizuoka
Other
The Effect of CoQ10 Administration on the Oxidative and Antioxidative Markers in Hemodialysis Patients
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02374372
Amyloidosis, Chronic Disease
Montreal, Quebec, Canada
View Trial DetailsNCT05631782
Chronic Disease, Chronic Renal Failure
Zunyi, China
View Trial DetailsNCT04089397
Chronic Disease, Chronic Renal Failure
Pringy, France
View Trial DetailsNCT00317005
Amino Acid Metabolism, Inborn Errors, Avitaminosis
Londrina, Paraná, Brazil
View Trial Details